Anti-malaria drug hydroxychloroquine championed by Donald Trump for coronavirus COVID-19 treatment fails another test, finds study
A new study has revealed that anti-malaria drug Hydroxychloroquine (HCQ) has failed another test to prove its efficiency in treating the coronavirus COVID-19, with infected patients showing no change in their conditions after being administered HCQ.
May 10, 2020, 06:21 AM IST